Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Bayer Invests US$250 million to Open New Cell Therapy Manufacturing Facility in USA
Bayer plans to open new cell therapy manufacturing facility with an investment of US$250 million The facility will be loacted in California, USA
The Keck School of Medicine of USC Plans to Open Cell Therapy Manufacturing Facility in USA
The Keck School of Medicine of USC plans to open new cell therapy manufacturing facility The facility will be located in USA
Novo Nordisk Unveils Plans to Expand US$6 billion (INR 507 billion) Manufacturing Facilities in Denmark, Europe
Novo Nordisk invests US$6 biilion INR 507 billion to expand its existing manufacturing facilities in Denmark, Europe
FUJIFILM Diosynth Biotechnologies Invests US$2 billion to Construct New Manufacturing Facility in North California, USA
FUJIFILM Diosynth Biotechnologies is investing US$2 billion to open new largescale cell culture manufacturing facility in North Carolina, USA
Pharmascience Invests US$120 million to Expand Injectable Manufacturing Facilities in Quebec, Canada
Pharmascience is investing US$120 million to expand its sterile injectable manufacturing facility in Qubec, Canada The expansion project triples
Umoja Biopharma Plans to Construct New Manufacturing Facility in Colourado, USA
Umoja Biopharma plans for the construction of a new stateoftheart laboratory and innovative manufacturing facility in Colourado, USA
The University of Nebraska Medical Centre Plans to Open New Research Building in USA
The University of Nebraska Medical Centre plans for the construction of new CORE campus operations and research excellence building in USA
Aragen Invests US$3 Million to Construct New Manufacturing Facility in India
Aragen invests US$3 million to open new stateoftheart formulations manufacturing facility in India This stateoftheart facility spans over 12,000 square
Avid Bioservices Invests US$400 million to Construct New Cell and Gene Manufacturing Facility in California, USA
Avid Bioservices is investing approximately US$400 million to construct a new worldclass cell and gene therapy development and manufacturing facility in California, USA
OBiO Technology Plans to Open New Production Facility in Shanghai, China
OBiO Technology unveiled to construct new stateoftheart GMP production facility, IntelliM for developing advanced therapies in Shanghai, China
